Dr. Deborah Birx responds to latest study on risks of hydroxycholoquine for COVID-19

White House coronavirus coordinator Dr. Deborah Birx was asked Friday about results of a new study showing COVID-19 patients got no benefit and suffered some serious side effects from the malaria drug President Trump has pushed as a possible treatment. She noted that many of those patients had other health issues. Watch her remarks.